The burden and risk factors for adverse drug events in older patients--a prospective cross-sectional study.

OBJECTIVE To determine the burden and risk factors for adverse drug events (ADEs) in older patients. Design. A prospective cross-sectional study. METHODS Patients (65 years and older) presenting to the tertiary Emergency Unit of Groote Schuur Hospital, Cape Town, between February and May 2005, were assessed for well established ADEs, as defined by the South African Medicines Formulary. Logistic regression models were fitted to determine drugs and other factors associated with the likelihood of developing ADEs. RESULTS ADEs were identified in 104 of the 517 (20%) presentations. The most frequently involved drug classes were cardiovascular (34%), anticoagulant (27%), analgesic (19%) and antidiabetic (9%). Patients who developed ADEs were more likely to have five or more prescription drugs (p < 0.0001), more than three clinical problems (p = 0.001), require admission (p = 0.04), and report compliance with medication (p = 0.02) than those who did not. Drugs shown to independently confer increased risk of ADEs were angiotensin-converting enzyme inhibitors (RR = 2.6, 95% CI: 1.3 - 5.2, p = 0.009), non-steroidal anti-inflammatory drugs (RR = 4.1, 95% CI: 2.1 - 8.0, p < 0.0001) and warfarin (RR = 3.1, 95% CI: 1.6 - 6.3, p = 0.0014). CONCLUSION ADEs contribute significantly to the burden of elderly care in the Emergency Unit. In a setting such as ours, increased pill burden and certain drug classes are likely to result in increased risk of ADEs in the older population group.

[1]  Christel L Burgess,et al.  Adverse drug reactions in older Australians, 1981–2002 , 2005, The Medical journal of Australia.

[2]  Colin Baigent,et al.  Low-dose aspirin for the prevention of atherothrombosis. , 2005, The New England journal of medicine.

[3]  D. Bates,et al.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting. , 2003, JAMA.

[4]  A. Wall,et al.  Book ReviewTo Err is Human: building a safer health system Kohn L T Corrigan J M Donaldson M S Washington DC USA: Institute of Medicine/National Academy Press ISBN 0 309 06837 1 $34.95 , 2000 .

[5]  A. Filippelli,et al.  Adverse drug events in two emergency departments in Naples, Italy: an observational study. , 2004, Pharmacological research.

[6]  M. Mcmurdo,et al.  Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. , 1997, Age and ageing.

[7]  S. Jain,et al.  Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance , 2001, Postgraduate medical journal.

[8]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[9]  R. Beyth,et al.  Epidemiology of Adverse Drug Reactions in the Elderly by Drug Class , 1999, Drugs & aging.

[10]  E. Hylek,et al.  Antithrombotic therapy in atrial fibrillation. , 2006, Clinics in geriatric medicine.

[11]  T. V. D. van der Cammen,et al.  Contribution of adverse drug reactions to hospital admission of older patients. , 2000, Age and ageing.

[12]  D. Nathan Initial Management of Glycemia in Type 2 Diabetes Mellitus , 2002 .

[13]  Sebastian Schneeweiss,et al.  Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study , 2002, European Journal of Clinical Pharmacology.

[14]  T. Avery,et al.  Inappropriate prescribing in older people. , 2004, Age and ageing.

[15]  J. Newton,et al.  Counting the true cost of antiplatelet therapy for stroke prevention. , 2005, Age and ageing.

[16]  J. Kelly,et al.  Beta-blocker use in elderly patients with coronary heart disease. , 2000, Age and ageing.

[17]  M. Afilalo,et al.  Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. , 2001, Annals of emergency medicine.

[18]  P. Barach,et al.  Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting , 2004, Annals of Internal Medicine.

[19]  Harlan M Krumholz,et al.  Association of serum digoxin concentration and outcomes in patients with heart failure. , 2003, JAMA.

[20]  D. Nathan Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. , 2002, The New England journal of medicine.

[21]  H. Wynne,et al.  Review: the frequency and severity of adverse drug reactions in elderly people. , 1995, Age and ageing.